VEKELTO Trademark

Trademark Overview


On Tuesday, June 30, 2020, a trademark application was filed for VEKELTO with the United States Patent and Trademark Office. The USPTO has given the VEKELTO trademark a serial number of 79291283. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by NOVARTIS AG. The VEKELTO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
vekelto

General Information


Serial Number79291283
Word MarkVEKELTO
Filing DateTuesday, June 30, 2020
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6224681
Registration DateTuesday, December 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Saturday, March 6, 2021NOTIFICATION PROCESSED BY IB
Monday, February 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 8, 2021FINAL DISPOSITION PROCESSED
Thursday, January 21, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, October 24, 2020NOTIFICATION PROCESSED BY IB
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 1, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 25, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 25, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 25, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 25, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 25, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 22, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, August 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 17, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB